Chimeric antigen receptor T-cell therapy after COVID-19 in refractory high-grade B-cell lymphoma
暂无分享，去创建一个
K. Seike | K. Fujii | H. Nishimori | K. Hayashino | Kanako Fujiwara | D. Ennishi | K. Kondo | C. Matsubara | Toshiki Terao | W. Kitamura | C. Kamoi | Hideaki Fujiwara | N. Asada | N. Fujii | Ken-Ichi Matsuoka | Y. Maeda